RDP58 is a novel and potentially effective oral therapy for ulcerative colitis. (Inflammatory bowel diseases, 2005)

(untitled) - Travis, S; Yap, L; Hawkey, C; Warren, B; Lazarov, M; Fong, T; Tesi, R